Ireland

--:--IST

Latest

Ireland Needs 46,000 More Digital Specialists by 2030, EGFSN Report Warns Project Management Failures: Lessons for Healthcare FDA Approves Lilly's Weekly Insulin Onswik to Rival Awiqli WeBuild Programme: 50+ Women-Led Ventures and How to Apply Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Ireland Needs 46,000 More Digital Specialists by 2030, EGFSN Report Warns Project Management Failures: Lessons for Healthcare FDA Approves Lilly's Weekly Insulin Onswik to Rival Awiqli WeBuild Programme: 50+ Women-Led Ventures and How to Apply Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing

Subscribe

Registers› Irish medicines ›Pramipexole dihydrochloride monohydrate

Medicines register · Ireland

Pramipexole dihydrochloride monohydrate — medicines in Ireland

30 authorised products containing Pramipexole dihydrochloride monohydrate, from the HPRA register.

Source: HPRA open dataset ("Authorised or Transfer Pending Products"), CC BY 4.0. Complete coverage — all 10,296 authorised products are in this register. Synced 07 Oct 2026, 03:23 UTC

Narrow the register Reset

Search within results

Matches brand name, active substance, licence holder and licence number.

Browse by first letter

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9

Medicine

Active substance

Licence holder

Status

Miramel 0.088 mg tablets PA0126/173/001

Pramipexole dihydrochloride monohydrate

Clonmel Healthcare Ltd

Marketed

Miramel 0.7 mg tablets PA0126/173/003

Pramipexole dihydrochloride monohydrate

Clonmel Healthcare Ltd

Marketed

MIRAPEXIN 0.088 mg tablets EU/1/97/051/001-002

Pramipexole dihydrochloride monohydrate

Boehringer Ingelheim International GmbH

—

MIRAPEXIN 0.18 mg tablets EU/1/97/051/003-004

Pramipexole dihydrochloride monohydrate

Boehringer Ingelheim International GmbH

—

MIRAPEXIN 0.26 mg prolonged-release tablets EU/1/97/051/13-15

Pramipexole dihydrochloride monohydrate

Boehringer Ingelheim International GmbH

—

MIRAPEXIN 0.35 mg tablets EU/1/97/051/011-012

Pramipexole dihydrochloride monohydrate

Boehringer Ingelheim International GmbH

—

MIRAPEXIN 0.52 mg prolonged-release tablets EU/1/97/051/16-18

Pramipexole dihydrochloride monohydrate

Boehringer Ingelheim International GmbH

—

MIRAPEXIN 0.7 mg tablets EU/1/97/051/005-006

Pramipexole dihydrochloride monohydrate

Boehringer Ingelheim International GmbH

—

MIRAPEXIN 1.05 mg prolonged-release tablets EU/1/97/051/19-21

Pramipexole dihydrochloride monohydrate

Boehringer Ingelheim International GmbH

—

MIRAPEXIN 1.57 mg prolonged-release tablets EU/1/97/051/028-30

Pramipexole dihydrochloride monohydrate

Boehringer Ingelheim International GmbH

—

MIRAPEXIN 2.1 mg prolonged-release tablets EU/1/97/051/22-24

Pramipexole dihydrochloride monohydrate

Boehringer Ingelheim International GmbH

—

MIRAPEXIN 2.62 mg prolonged-release tablets EU/1/97/051/031-33

Pramipexole dihydrochloride monohydrate

Boehringer Ingelheim International GmbH

—

MIRAPEXIN 3.15 mg prolonged-release tablets EU/1/97/051/25-27

Pramipexole dihydrochloride monohydrate

Boehringer Ingelheim International GmbH

—

Oprymea 2.62 mg prolonged-release tablets EU/1/08/469/046-049

Pramipexole dihydrochloride monohydrate

KRKA, d.d., Novo mesto

—

Oprymea 3.15 mg prolonged-release tablets EU/1/08/469/050-053

Pramipexole dihydrochloride monohydrate

KRKA, d.d., Novo mesto

—

Pramipexole Teva 0.088 mg tablets EU/1/08/490/1-4

Pramipexole dihydrochloride monohydrate

Teva Pharma B.V.

—

Pramipexole Teva 0.18 mg tablets EU/1/08/490/5-8

Pramipexole dihydrochloride monohydrate

Teva Pharma B.V.

—

Pramipexole Teva 0.35 mg tablets EU/1/08/490/9-12

Pramipexole dihydrochloride monohydrate

Teva Pharma B.V.

—

Pramipexole Teva 0.7 mg tablets EU/1/08/490/13-16

Pramipexole dihydrochloride monohydrate

Teva Pharma B.V.

—

SIFROL 0.088 mg tablets EU/1/97/050/001-002

Pramipexole dihydrochloride monohydrate

Boehringer Ingelheim International GmbH

—

SIFROL 0.18 mg tablets EU/1/97/050/003-004

Pramipexole dihydrochloride monohydrate

Boehringer Ingelheim International GmbH

—

SIFROL 0.26 mg prolonged-release tablets EU/1/97/050/013-015

Pramipexole dihydrochloride monohydrate

Boehringer Ingelheim International GmbH

—

SIFROL 0.35 mg tablets EU/1/97/050/011-012

Pramipexole dihydrochloride monohydrate

Boehringer Ingelheim International GmbH

—

SIFROL 0.52 mg prolonged-release tablets EU/1/97/050/016-018

Pramipexole dihydrochloride monohydrate

Boehringer Ingelheim International GmbH

—

SIFROL 0.7 mg tablets EU/1/97/050/005-006

Pramipexole dihydrochloride monohydrate

Boehringer Ingelheim International GmbH

—

SIFROL 1.05 mg prolonged-release tablets EU/1/97/050/19-21

Pramipexole dihydrochloride monohydrate

Boehringer Ingelheim International GmbH

—

SIFROL 1.57 mg prolonged-release tablets EU/1/97/050/028-30

Pramipexole dihydrochloride monohydrate

Boehringer Ingelheim International GmbH

—

SIFROL 2.1 mg prolonged-release tablets EU/1/97/050/22-24

Pramipexole dihydrochloride monohydrate

Boehringer Ingelheim International GmbH

—

SIFROL 2.62 mg prolonged-release tablets EU/1/97/050/031-33

Pramipexole dihydrochloride monohydrate

Boehringer Ingelheim International GmbH

—

SIFROL 3.15 mg prolonged-release tablets EU/1/97/050/25-27

Pramipexole dihydrochloride monohydrate

Boehringer Ingelheim International GmbH

—

Cite this view

Priya Life Science (2026). Irish Medicines Register, filtered. Derived from the HPRA open dataset. Retrieved 7 October 2026. https://priyalifescience.com/medicines/substance/pramipexole-dihydrochloride-monohydrate

Download this register

GET /api/export.php?register=medicines-ie&format=csv Try the JSON export →

Regulatory information only — not medical advice. For the authoritative record see the HPRA register directly.